Streetbeat News

Regulatory

SPY

Federal Reserve's Harker has stated that the current interest rate environment is draining the housing market of new buyers. He also reiterated that the U.S. Central Bank is very likely done with rate hikes.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 2:32 pm

SPY

VGK

U.S. Treasury Secretary Janet Yellen has expressed confidence that Congress will approve aid for Ukraine, despite current opposition. Both the U.S. and EU are committed to supporting Ukraine.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 2:31 pm

SPY

VGK

U.S. Treasury Secretary Yellen stated that decoupling from China is not an option for the U.S. or EU. The White House is also preparing a supplemental request for aid to Ukraine and Israel.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 2:30 pm

AZN

AstraZeneca's supplemental New Drug Application for Tagrisso in combination with chemotherapy has been granted Priority Review by the FDA for locally advanced or metastatic non-small cell lung cancer (NSCLC). The FDA decision is expected in Q1 2024. The application is based on data from the FLAURA2 Phase 3 trial, which showed that the combination reduced the risk of disease progression or death by 38% compared to Tagrisso alone. AstraZeneca's shares are up 0.04% at $67.36.

Portfolio Pulse from Vandana Singh

October 16, 2023 | 2:20 pm

GEHC

GE HealthCare (NASDAQ:GEHC) has received FDA clearance for its Allia IGS Pulse, a next-generation image-guided system designed for cardiac imaging. The system is designed to improve workflow for diagnosing and treating cardiovascular diseases. It features the first monopolar x-ray tube used for interventional procedures, providing exceptional image quality and optimized dose management for all patient sizes. The Allia IGS Pulse has been in pilot operations at Clinique Pasteur in Toulouse, France since January 2023.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 2:17 pm

BLK

Bitcoin spiked on unverified reports of the approval of an iShares Bitcoin ETF, which BlackRock, the owner of iShares, has denied. The company's Bitcoin ETF application is still under review. Bitcoin had spiked by as much as 9.5% after the report but gave back gains. It is up 3.3% at $28,062 at the time of publication.

Portfolio Pulse from Mohit Manghnani

October 16, 2023 | 2:08 pm

ALDX

BIOC

LQR

MNTS

OMER

PCTI

U.S. stocks traded higher with the Dow Jones index gaining over 200 points. The NY Empire State Manufacturing Index declined to -4.6 in October. LQR House Inc. shares rose 76% after announcing its product is now available at Costco. PCTEL, Inc. shares rose 47% after Amphenol Corp agreed to acquire it. Momentus Inc. shares rose 32%. Aldeyra Therapeutics shares dropped 60% after FDA feedback on their new drug application. Biocept, Inc. shares dropped 58% after the CEO's resignation and filing for bankruptcy. Omeros Corporation shares fell 47% after discontinuing a trial.

Portfolio Pulse from Lisa Levin

October 16, 2023 | 2:08 pm

VRNOF

A lawsuit filed by Verano Holdings Corp. against the Alabama Medical Cannabis Commission (AMCC) has been dismissed by Montgomery County Circuit Court Judge James Anderson. The lawsuit alleged that the AMCC had no right to revoke licenses. Verano had initially secured a license in June, which was later revoked due to 'scoring errors' in the application process. The dismissal of the lawsuit comes ahead of Verano's Class A subordinate voting shares beginning to trade on Canada's Neo Exchange Inc., operating as Cboe Canada, on October 18, 2023. Verano's shares closed 1.4118% higher at $4.31 per share on Friday.

Portfolio Pulse from Jelena Martinovic

October 16, 2023 | 2:04 pm

BTCUSD

Bitcoin's price has slightly increased but is coming down from its highs due to false rumors about the approval of the iShares Bitcoin Spot ETF.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 2:02 pm

BTCUSD

The U.S. Securities and Exchange Commission (SEC) has not approved the iShares Bitcoin Spot ETF as previously reported. The application is still under review, according to Fox Business Reporter.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 1:53 pm